Nitric oxide acts as an epigenetic regulator of histone H3K9 acetylation in oviduct cells in luteal and follicular phase of estrous cycle
Heloise Cale da Rocha, Patricia Kubo Fontes, Joana Claudio Pieretti, Jéssica Ispada, Aldcejam Martins da Fonseca Junior, João Vitor Alcantara da Silva, Amedea Barozzi Seabra, Marcella Percora Milazzotto
Abstract
Reproductive events that occur in the oviduct depend on signaling molecules, e.g. nitric oxide (NO). The NO, a short-lived free radical, has a variety of cellular effects, including alterations in mitochondrial metabolism and participation in reproductive processes such as fertilization and preimplantation embryo development. Recently, NO has also been associated to Histone Deacetylase 2 (HDAC2) function in neurons, resulting in altered pattern of histone acetylation, with consequences to the gene expression. Thus, this study aimed to analyze whether differences in the NO availability in the bovine oviduct epithelial cells (BOEC) lead to changes in the mitochondrial metabolism and in the histone H3K9 acetylation profile (H3K9ac). BOEC were collected from a slaughterhouse from animals at luteal (L) or follicular (F) phases (set by ovarian morphology). In total, 12 animals were selected and divided in three replicates. In each replicate, BOEC of the same estrous cycle phase (n=2 animals/ phase) were pooled and cultured in DMEM + 10% FBS (38°C, 5% CO2, high humid) until 70% confluence, moment when the cells were submitted to the treatments. Cells were treated with S-Nitrosoglutathione (GSNO), a nitric oxide donor, in three concentrations: zero (control), 100 (GSNO100), and 500 μM (GSNO500). Therefore, six groups were analyzed according to the treatment and the estrous cycle phase: control follicular (CF), control luteal (CL), GSNO100F, GSNO100L, GSNO500F, and GSNO500L. The mitochondrial membrane potential (MMP) was analyzed by fluorescent probe and the H3K9ac levels by immunocytochemistry, both analysis were done at 0h (before treatment), 4h, 48h, and 96h after addition of GSNO (0, 100, and 500 μM). Microscopy images were processed by the Fiji package and the data analyzed by the GraphPad Prism software (Kruskal-Wallis test for non-parametric data and Tukey test for parametric data, p 4h = 48h > 96h), while the GSNO100L treatment led to higher H3K9ac levels at 4h and 48h than their respectively control groups and the GSNO500L treatment had a later effect increasing the H3K9ac levels at 48h and 96h compared to their respectively control groups. In conclusion, NO acts to increase H3K9ac levels in oviductal cells, which might occur by inhibiting HDACs, however this modulation seems to be dependent on the estrous cycle phase.
